Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
The Real Reason Birth Control Has Placebo Pills
The pill comprises 40% of the profits in the U.S. contraceptive market and 25% of contraceptive consumers, causing millions of unnecessary ‘periods’ along the way. So, why hasn’t birth control evolved beyond the pseudo-period?
NASA Names DC HQ for 'Hidden Figures' Engineer
NASA on Friday is named its Washington headquarters after Mary W. Jackson, the space agency's first African American female engineer whose story was portrayed in the popular film "Hidden Figures."
Load More